Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nano Chemical Systems Holdings has entered into a letter of intent for the acquisition of Calgenex, a developer of novel, patented or patent pending, condition specific dietary supplements and topical over-the-counter drugs and personal care products.
Subscribe to our email newsletter
Grant Carlson, Calgenex president & CEO, said: “The move to the public marketplace has always been in our long term plans. The increased access to capital, as well as the opportunity to create tremendous shareholder value makes the move into Nanochem a perfect fit.”